BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans.
Saved in:
| Title: | BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans. |
|---|---|
| Authors: | Sivakumaran H; QIMR Berghofer, Brisbane, 4029, Australia., Nair S; QIMR Berghofer, Brisbane, 4029, Australia., Bitar M; QIMR Berghofer, Brisbane, 4029, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, 4006, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia., Lu X; QIMR Berghofer, Brisbane, 4029, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia., Wang L; QIMR Berghofer, Brisbane, 4029, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, 4006, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia., Liu J; QIMR Berghofer, Brisbane, 4029, Australia., Karunarathne DS; QIMR Berghofer, Brisbane, 4029, Australia., Prakrithi P; QIMR Berghofer, Brisbane, 4029, Australia.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4006, Australia., Jacquelin S; QIMR Berghofer, Brisbane, 4029, Australia.; Macrophage Biology Laboratory, Mater Research, Brisbane, 4102, Australia., Rivera IS; QIMR Berghofer, Brisbane, 4029, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, 4006, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia., Hillman KM; QIMR Berghofer, Brisbane, 4029, Australia., Kaufmann S; QIMR Berghofer, Brisbane, 4029, Australia., Ziegman R; QIMR Berghofer, Brisbane, 4029, Australia., Shi W; QIMR Berghofer, Brisbane, 4029, Australia., Alexandrou S; Garvan Institute of Medical Research, Sydney, 2010, Australia.; Faculty of Medicine, St Vincent's Clinical School, UNSW Sydney, Sydney, 2010, Australia., Caldon CE; Garvan Institute of Medical Research, Sydney, 2010, Australia.; Faculty of Medicine, St Vincent's Clinical School, UNSW Sydney, Sydney, 2010, Australia., Veedu RN; Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, 6150, Australia.; Precision Nucleic Acid Therapeutics, Perron Institute for Neurological and Translational Science, Perth, 6009, Australia., Nguyen QH; QIMR Berghofer, Brisbane, 4029, Australia.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4006, Australia., Beesley J; QIMR Berghofer, Brisbane, 4029, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia., Wykes MN; QIMR Berghofer, Brisbane, 4029, Australia., French JD; QIMR Berghofer, Brisbane, 4029, Australia. Juliet.French@qimrb.edu.au.; Faculty of Health, Queensland University of Technology, Brisbane, 4006, Australia. Juliet.French@qimrb.edu.au.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia. Juliet.French@qimrb.edu.au., Edwards SL; QIMR Berghofer, Brisbane, 4029, Australia. Stacey.Edwards@qimrb.edu.au.; Faculty of Health, Queensland University of Technology, Brisbane, 4006, Australia. Stacey.Edwards@qimrb.edu.au.; School of Biomedical Sciences, The University of Queensland, Brisbane, 4006, Australia. Stacey.Edwards@qimrb.edu.au. |
| Source: | Molecular cancer [Mol Cancer] 2026 Jan 07; Vol. 25 (1), pp. 5. Date of Electronic Publication: 2026 Jan 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
